Key Takeaways BDX posted Q4 adjusted EPS of $3.96, up 3.9$5.89 billion, driven by growth across all segments, especially BD Medical.BDX's gross and operating margins expanded 176 bps each, signaling improved profitability.Becton, Dickinson and Company (BDX) , popularly known as BD, delivered adjusted earnings per share (EPS) of $3.96 in the fourth quarter of fiscal 2025, up 3.9% year over year. The figure topped the Zacks Consensus Estimate ...